CCM
Citizens Capital Markets Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
1
Charles Schwab
SCHW
$170B
|
DR
Devin Ryan
| $93.46 | $110 |
18%
upside
| Market Perform |
21 Jul ‘25
1 month ago |
|
2
Xometry
XMTR
$2.63B
|
AB
Andrew Boone
| $51.79 | $40 |
23%
downside
| Market Outperform |
22 Apr ‘25
4 months ago |
|
3
Paylocity
PCTY
$9.54B
|
PW
Patrick Walravens
| $173.03 | $270 |
56%
upside
| Market Outperform |
3 Apr ‘25
5 months ago |
|
4
Cytokinetics
CYTK
$6.23B
|
JB
Jason Butler
| $52.06 | $78 |
50%
upside
| Market Outperform |
3 Apr ‘25
5 months ago |
|
5
Roku
ROKU
$14.6B
|
MC
Matthew Condon
| $99.38 | $115 |
16%
upside
| Market Outperform |
2 Apr ‘25
5 months ago |
|
6
Sportradar
SRAD
$9.17B
|
JB
Jordan Bender
| $30.98 | $25 |
19%
downside
| Market Outperform |
2 Apr ‘25
5 months ago |
|
7
nCino
NCNO
$3.57B
|
AK
Aaron Kimson
| $30.82 | $32 |
4%
upside
| Market Outperform |
2 Apr ‘25
5 months ago |
|
8
DraftKings
DKNG
$23B
|
JB
Jordan Bender
| $46.33 | $57 |
23%
upside
| Market Outperform |
2 Apr ‘25
5 months ago |
|
9
Cue Biopharma
CUE
$60.2M
|
RB
Reni Benjamin
| $0.7830 | $2 |
155%
upside
| Market Outperform |
2 Apr ‘25
5 months ago |
|
10
AtriCure
ATRC
$1.79B
|
DS
Daniel Stauder
| $36 | $60 |
67%
upside
| Market Outperform |
2 Apr ‘25
5 months ago |
|
11
Altimmune
ALT
$327M
|
JW
Jonathan Wolleben
| $3.71 | $25 |
574%
upside
| Market Outperform |
2 Apr ‘25
5 months ago |
|
|
LIF
12
Life360
LIF
$8B
|
AB
Andrew Boone
| $103.13 | $55 |
47%
downside
| Market Outperform |
1 Apr ‘25
5 months ago |
|
13
Gaming and Leisure Properties
GLPI
$13.6B
|
MG
Mitch Germain
| $47.94 | $55 |
15%
upside
| Market Outperform |
1 Apr ‘25
5 months ago |
|
14
BioAtla
BCAB
$35.9M
|
RB
Reni Benjamin
| $0.6113 | $1 |
64%
upside
| Market Outperform |
31 Mar ‘25
5 months ago |
|
15
Lennar Class A
LEN
$36.9B
|
AH
Aaron Hecht
| $142.42 | $150 |
5%
upside
| Market Outperform |
31 Mar ‘25
5 months ago |
|
16
Meta Platforms (Facebook)
META
$1.89T
|
AB
Andrew Boone
| $752.31 | $750 |
0%
downside
| Market Outperform |
28 Mar ‘25
5 months ago |
|
17
Global Net Lease
GNL
$1.82B
|
MG
Mitch Germain
| $8.24 | $9 |
9%
upside
| Market Outperform |
28 Mar ‘25
5 months ago |
|
18
Clearside Biomedical
CLSD
$26.8M
|
JW
Jonathan Wolleben
| $0.3415 | $5 |
1,364%
upside
| Market Outperform |
28 Mar ‘25
5 months ago |
|
19
Braze
BRZE
$3.59B
|
PW
Patrick Walravens
| $32.29 | $68 |
111%
upside
| Market Outperform |
28 Mar ‘25
5 months ago |
|
|
MFA
20
MFA Financial
MFA
$1.06B
|
TC
Trevor Cranston
| $10.34 | $12.50 |
21%
upside
| Market Outperform |
26 Mar ‘25
5 months ago |
|
21
KalVista Pharmaceuticals
KALV
$804M
|
JW
Jonathan Wolleben
| $15.97 | $19 |
19%
upside
| Market Outperform |
26 Mar ‘25
5 months ago |
|
22
Guidewire Software
GWRE
$22.1B
|
AK
Aaron Kimson
| $261.99 | $250 |
5%
downside
| Market Outperform |
26 Mar ‘25
5 months ago |
|
23
Aura Biosciences
AURA
$401M
|
JW
Jonathan Wolleben
| $6.46 | $19 |
194%
upside
| Market Outperform |
26 Mar ‘25
5 months ago |
|
24
AN2 Therapeutics
ANTX
$33.3M
|
RB
Roy Buchanan
| $1.22 | $5 |
310%
upside
| Market Outperform |
26 Mar ‘25
5 months ago |
|
25
Acrivon Therapeutics
ACRV
$56.6M
|
ST
Silvan Tuerkcan
| $1.80 | $17 |
844%
upside
| Market Outperform |
26 Mar ‘25
5 months ago |
|